SPDR® S&P Pharmaceuticals ETF (NYSEARCA:XPH) is a distinctive exchange-traded fund that focuses on the pharmaceuticals sector. It aims to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index. The ETF covers a diverse range of companies within the pharmaceutical industry, including those involved in the research, development, production, and marketing of pharmaceuticals and drugs of all types. The fund's projects and objectives are centered around capturing the dynamics of the pharmaceutical sector, providing investors exposure to this vital industry through a single investment. By tracking the S&P Pharmaceuticals Select Industry Index, SPDR® S&P Pharmaceuticals aims to offer a comprehensive representation of the pharmaceutical market. This ETF is designed for investors looking to tap into the growth potential of the pharmaceutical industry while spreading out their risk across multiple companies within this sector.